CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 28 enrolled
Drug / intervention
Oligofructose +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00912197
NCT00912197N/ACompleted
CompareCT.gov

Effect of Oligofructose on Appetite, Gut Hormones and Body Composition in Healthy Overweight Subjects

Imperial College London·interventional·Posted Jun 3, 2009·Updated Jan 14, 2021

In Brief

A clinical study evaluating Oligofructose and Placebo for Appetite Regulation and Obesity. Completed, enrolled 28 participants across 1 site.

Detailed Summary

This study seeks to look into the effects of oligofructose supplementation on appetite, energy intake, and body weight and body composition in overweight subjects. Compared to a placebo product (cellulose) oligofructose is hypothesised to suppress hunger and thereby reduce food intake moderately leading to a decrease in body weight.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAppetite Regulation, Obesity
CountriesUnited Kingdom
Collaborators--

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedJun 3, 2009
Enrollment StartJun 1, 2009
Primary CompletionAug 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 17.1 years ago

Interventions

Oligofructosedietary

Participants will be asked to consume 30g of oligofructose daily for six weeks after a 2-week run-in.

Placebodietary

Participants will be asked to consume 3 doses (a total of 30g dietary fibres) of the placebo product daily for six weeks after a 2-week run-in